P 19. Threshold for neurodegeneration and microstructural changes in different cell types induced by anodal transcranial direct current stimulation

Introduction Transcranial direct current stimulation (tDCS) has been shown to modulate cortical excitability and to improve motor learning (Nitsche and Paulus, 2000; Reis et al., 2009; Fritsch et al., 2010) . To date there is no data available on the safety aspects of tDCS covering a broad range of...

Full description

Saved in:
Bibliographic Details
Published inClinical neurophysiology Vol. 124; no. 10; pp. e72 - e73
Main Authors Gellner, A.-K, Reis, J, Ludwig, V.E, Galbusera, R, Weiller, C, Fritsch, B
Format Journal Article
LanguageEnglish
Published Elsevier Ireland Ltd 01.10.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction Transcranial direct current stimulation (tDCS) has been shown to modulate cortical excitability and to improve motor learning (Nitsche and Paulus, 2000; Reis et al., 2009; Fritsch et al., 2010) . To date there is no data available on the safety aspects of tDCS covering a broad range of stimulation intensities, thus limitations for dosages applied to humans are still based empirically on other types of electrical brain stimulation (Agnew and McCreery, 1987). Objectives The aim of this study was to investigate lesion threshold, accompanying neurodegeneration and possible microstructural changes in glial cells in an animal model of tDCS. Methods The tDCS electrode was placed in a screw tube surgically fixed on the skull above the left primary motor cortex of 47 Male Sprague Dawley rats. Anodal tDCS was applied in different intensities (254.8, 127.4, 63.7, 31.8, 15.9 and 8 A/sqm) or as sham stimulation for 20 min under slight isoflurane anesthesia. For each intensity animals were sacrificed either 24 h (acute effects) or 7 days (chronic effects) after intervention. Histological analyses of neurodegeneration (HE-staining, Fluoro-Jade C), astrocyte (anti-GFAP) and microglial (anti-CD11b [OX-42]) cell counts/density and/or morphological changes were evaluated. Results Macroscopical lesions could be observed at tDCS intensity of 127 A/sqm and above whereas the lesion dose 50 (LD 50) for microscopical neurodegeneration was determined at 60 A/sqm. Threshold for damage in neuronal and glial cells and change in morphology (activation) was identical. These changes could be detected both in the acute and chronic group. Notably, signs of still ongoing neurodegeneration, though to a slighter extent, were seen 7 days after stimulation. Brain swelling, which was seen underneath the stimulation electrode 24 h following the highest intensity used, was not present one week after stimulation. Conclusions Our results demonstrate that the LD 50 intensity of anodal tDCS for unwanted structural effects is 75 times higher than the intensities applied to humans to date. Additional safety derives from the fact that structures between brain and stimulation electrode, which lead to energy absorbtion, are thicker in humans compared to rats. Cell death, as a trigger for glial reaction, continues even 7 days after the intervention. Based on our results we conclude that higher tDCS intensities in human studies can be applied without risking structural damage.
ISSN:1388-2457
1872-8952
DOI:10.1016/j.clinph.2013.04.097